Table 3

Univariate log-rank analyses

Parameters	Category	No of cases	DSS		MEFS		LRFS
Parameters	Category	No of cases	No of events	p Value	No of events	p Value	No of events	p Value
Gender	Male	26	12	0.8484	9	0.4322	6	0.5228
Gender	Female	82	38	0.8484	34	0.4322	22	0.5228
Age (years)	<60	89	44	0.2502	39	0.1282	23	0.9133
Age (years)	≥60	19	6	0.2502	4	0.1282	5	0.9133
Primary tumour (T)	T1–T2	64	24	0.0611	18	0.0054^*	13	0.0539
Primary tumour (T)	T3–T4	44	26	0.0611	25	0.0054^*	15	0.0539
Nodal status (N)	N0–N1	42	12	0.0019^*	13	0.0369^*	7	0.0212^*
Nodal status (N)	N2–N3	66	38	0.0019^*	30	0.0369^*	21	0.0212^*
Stage	I–II	25	6	0.0211^*	6	0.0509	2	0.0112^*
Stage	II–IV	83	44	0.0211^*	37	0.0509	26	0.0112^*
Histological grade	Keratinised/non-keratinised	52	19	0.0570	16	0.0510	15	0.8452
Histological grade	Undifferentiated	56	31	0.0570	27	0.0510	13	0.8452
Rsf1	Low expression (0+∼2+)	59	13	<0.0001^*	14	<0.0001^*	7	<0.0001^*
Rsf1	Overexpression (3+∼4+)	49	37	<0.0001^*	29	<0.0001^*	21	<0.0001^*
Therapeutic response (n=101)	Partial response	7	5	0.1007	6	0.0045^*	1	0.9578
Therapeutic response (n=101)	Complete response	94	44	0.1007	36	0.0045^*	26	0.9578

↵* Statistically significant.
DSS, disease-specific survival; LRFS, local recurrence-free survival; MFS, metastasis-free survival.
The bold type is used to highlight the p-value with statistical significance.